Showing results (881-890 of 2,951) with videos related to
Sort By:
Pageof 296
Cancer Investigation|September 30, 2010
Statins use and risk for brain metastasis from lung cancerD Leigh, J Eken, J R Beal, et al.Cancer Investigation|September 30, 2010
Clinical significance of GPR56, transglutaminase 2, and NF-κB in esophageal squamous cell carcinomaTasneem Kausar, Rinu Sharma, Md Raghibul Hasan, et al.Cancer Investigation|May 21, 2010
Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: a phase II studyMichele Orditura, Gennaro Galizia, Vincenzo Napolitano, et al.Cancer Investigation|April 17, 2010
ZBTB7 overexpression contributes to malignancy in breast cancerHongyan Qu, Danni Qu, Fuhui Chen, et al.Cancer Investigation|May 30, 2009
Taxanes in the adjuvant treatment of early breast cancer, emerging consensus and unanswered questionsShou-Ching TangCancer Investigation|June 3, 2009
A caspase-6 and anti-HER2 antibody chimeric tumor-targeted proapoptotic molecule decreased metastasis of human osteosarcomaLi-Feng Wang, Yong Zhou, Yan-Ming Xu, et al.Cancer Investigation|May 28, 2010
Autocrine motility factor receptor signaling pathway promotes cell invasion via activation of ROCK-2 in esophageal squamous cell cancer cellsLili Wang, Guiqin Hou, Lexun Xue, et al.Cancer Investigation|May 28, 2010
Cetuximab insufficiently inhibits glioma cell growth due to persistent EGFR downstream signalingBenedikte Hasselbalch, Ulrik Lassen, Hans S Poulsen, et al.Cancer Investigation|May 15, 2009
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanomaAgop Y Bedikian, Nicholas E Papadopoulos, Kevin B Kim, et al.Cancer Investigation|July 29, 2009
Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approachZhu Qingyi, Yuan Lin, Wang Junhong, et al.Pageof 296